Short‐term effects of verapamil and diltiazem in the treatment of no reflow phenomenon: a meta‐analysis of randomized controlled trials
L Wang, Z Cheng, Y Gu, D Peng - BioMed Research …, 2015 - Wiley Online Library
Currently, there is still a lack of an optimal treatment for no reflow phenomenon (NRP). We
analyzed the efficacy and safety of using nondihydropyridine calcium channel antagonists …
analyzed the efficacy and safety of using nondihydropyridine calcium channel antagonists …
Short-Term Effects of Verapamil and Diltiazem in the Treatment of No Reflow Phenomenon: A Meta-Analysis of Randomized Controlled Trials
L Wang, Z Cheng, Y Gu, D Peng - BioMed Research …, 2015 - search.proquest.com
Currently, there is still a lack of an optimal treatment for no reflow phenomenon (NRP). We
analyzed the efficacy and safety of using nondihydropyridine calcium channel antagonists …
analyzed the efficacy and safety of using nondihydropyridine calcium channel antagonists …
[PDF][PDF] Short-Term Effects of Verapamil and Diltiazem in the Treatment of No Reflow Phenomenon: A Meta-Analysis of Randomized Controlled Trials
L Wang, Z Cheng, Y Gu, D Peng - 2015 - Citeseer
Currently, there is still a lack of an optimal treatment for no reflow phenomenon (NRP). We
analyzed the efficacy and safety of using nondihydropyridine calcium channel antagonists …
analyzed the efficacy and safety of using nondihydropyridine calcium channel antagonists …
[HTML][HTML] Short-Term Effects of Verapamil and Diltiazem in the Treatment of No Reflow Phenomenon: A Meta-Analysis of Randomized Controlled Trials
L Wang, Z Cheng, Y Gu, D Peng - BioMed Research International, 2015 - ncbi.nlm.nih.gov
Currently, there is still a lack of an optimal treatment for no reflow phenomenon (NRP). We
analyzed the efficacy and safety of using nondihydropyridine calcium channel antagonists …
analyzed the efficacy and safety of using nondihydropyridine calcium channel antagonists …
Short-Term Effects of Verapamil and Diltiazem in the Treatment of No Reflow Phenomenon: A Meta-Analysis of Randomized Controlled Trials
L Wang, Z Cheng, Y Gu, D Peng - BioMed research …, 2015 - pubmed.ncbi.nlm.nih.gov
Currently, there is still a lack of an optimal treatment for no reflow phenomenon (NRP). We
analyzed the efficacy and safety of using nondihydropyridine calcium channel antagonists …
analyzed the efficacy and safety of using nondihydropyridine calcium channel antagonists …
Short-term effects of verapamil and diltiazem in the treatment of no reflow phenomenon: a meta-analysis of randomized controlled trials
L Wang, Z Cheng, Y Gu, D Peng - BioMed Research International, 2015 - go.gale.com
Currently, there is still a lack of an optimal treatment for no reflow phenomenon (NRP). We
analyzed the efficacy and safety of using nondihydropyridine calcium channel antagonists …
analyzed the efficacy and safety of using nondihydropyridine calcium channel antagonists …
Short-Term Effects of Verapamil and Diltiazem in the Treatment of No Reflow Phenomenon: A Meta-Analysis of Randomized Controlled Trials.
L Wang, Z Cheng, Y Gu, D Peng - Biomed Research International, 2015 - europepmc.org
Currently, there is still a lack of an optimal treatment for no reflow phenomenon (NRP). We
analyzed the efficacy and safety of using nondihydropyridine calcium channel antagonists …
analyzed the efficacy and safety of using nondihydropyridine calcium channel antagonists …
[PDF][PDF] Short-Term Effects of Verapamil and Diltiazem in the Treatment of No Reflow Phenomenon: A Meta-Analysis of Randomized Controlled Trials
L Wang, Z Cheng, Y Gu, D Peng - 2015 - pdfs.semanticscholar.org
Currently, there is still a lack of an optimal treatment for no reflow phenomenon (NRP). We
analyzed the efficacy and safety of using nondihydropyridine calcium channel antagonists …
analyzed the efficacy and safety of using nondihydropyridine calcium channel antagonists …
[PDF][PDF] Short-Term Effects of Verapamil and Diltiazem in the Treatment of No Reflow Phenomenon: A Meta-Analysis of Randomized Controlled Trials
L Wang, Z Cheng, Y Gu, D Peng - 2015 - Citeseer
Currently, there is still a lack of an optimal treatment for no reflow phenomenon (NRP). We
analyzed the efficacy and safety of using nondihydropyridine calcium channel antagonists …
analyzed the efficacy and safety of using nondihydropyridine calcium channel antagonists …
Short-Term Effects of Verapamil and Diltiazem in the Treatment of No Reflow Phenomenon: A Meta-Analysis of Randomized Controlled Trials.
L Wang, Z Cheng, Y Gu, D Peng - Biomed Research International, 2015 - europepmc.org
Currently, there is still a lack of an optimal treatment for no reflow phenomenon (NRP). We
analyzed the efficacy and safety of using nondihydropyridine calcium channel antagonists …
analyzed the efficacy and safety of using nondihydropyridine calcium channel antagonists …